Compass Therapeutics to Participate in Upcoming Investor Events
- Compass Therapeutics, Inc. (Nasdaq: CMPX) will participate in investor events in June 2023. The company will present at the Jefferies Global Healthcare Conference on June 8 at 2 PM ET. They will also be part of a panel at the World Medical Innovation Forum on June 13 at 8:30 AM ET.
- None.
BOSTON, June 01, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of June 2023.
Details are as follows:
Jefferies Global Healthcare Conference
Location: New York, NY
Format: Presentation
Date: Thursday, June 8
Time: 2-2:25 PM ET
Webcast Link: https://wsw.com/webcast/jeff281/cmpx/1864720
World Medical Innovation Forum hosted by Mass General Brigham Innovation and Bank of America
Location: Boston, MA
Format: Panel: The Disruptors: The Biologic Revolution in Cancer Continues
Date: Tuesday, June 13
Time: 8:30-9:30 AM ET
Virtual/Replay availability: Presentations will be archived for 90 days on Compass’ Events page.
About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.
Investor Contact
ir@compasstherapeutics.com
Media Contact
Anna Gifford, Communications Manager
media@compasstherapeutics.com
617-500-8099
FAQ
What investor events will Compass Therapeutics participate in June 2023?
When is the presentation at the Jefferies Global Healthcare Conference?
What is the topic of the panel at the World Medical Innovation Forum?
Where can I find the webcast of the Jefferies Global Healthcare Conference presentation?
How long will the presentations be available for replay?
